Unidrug Innovative Pharma Technologies Limited - Company Profile

It is a pharma public limited company based in Indore, Madhya Pradesh, India, established in 1987.
1987 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Unidrug Innovative Pharma Technologies Limited

Unidrug Innovative Pharma Technologies Limited, a active public limited company, was established on 13 March 1987 in Indore, Madhya Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U85120MP1987PLC003875. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹9.58 Cr.

Formerly known as Uni Drug Ltd, Uni Drug Pvt Ltd. It upholds a compliant status. Employing 33 professional, Its leadership includes Jainesh Jain (Managing Director), Gajanand Agrawal (Director), Bharat Jain (Director). Past directors included Kanaklata Jain, Mahesh Asawa Chandra, Niresh Maheshwari. It holds ₹40.49 Cr open charges and ₹16.87 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 84 A, Sector - E Sanwer Road, Indore, Madhya Pradesh, 452015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85120MP1987PLC003875

  • Registration Number

    003875

  • Incorporation Date

    13 March 1987

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹9.58 Cr

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 9.58 Cr
  • Company Age 38 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 40.49 Cr
  • Satisfied Charges ₹ 16.87 Cr
  • Revenue Growth **** 0.38%
  • Profit Growth **** -23.85%
  • Ebitda **** -17.28%
  • Net Worth 13.71%
  • Total Assets **** 14.32%
Company report

Unidrug Innovative Pharma Technologies Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unidrug Innovative Pharma Technologies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Unidrug Innovative Pharma Technologies Limited?
Current Directors
Name Designation Appointment Date Status
Jainesh Jain Managing Director 20 Aug 1995 Current
Gajanand Agrawal Director 20 Sep 2018 Current
Bharat Jain Director 20 Sep 2018 Current
Varsha Jain Director 05 Oct 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Sep 2018 Past
Pramod Abcsdd Director 10 Apr 2021 Past
Pramod Abcsdd Additional Director 23 Aug 2019 Past
Pramod Abcsdd Additional Director 09 Dec 2008 Past
Pramod Abcsdd Additional Director 09 Dec 2008 Past
Pramod Abcsdd Additional Director 23 Aug 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unidrug Innovative Pharma Technologies.

Unidrug Innovative Pharma Technologies Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.38% increase. The company also saw a substantial fall in profitability, with a 23.85% decrease in profit. The company's net worth Soared by an impressive increase of 13.71%.

Unidrug Innovative Pharma Technologies revenue growth over time
Unidrug Innovative Pharma Technologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.38%
*******
*******
*******
*******
Revenue from Operations
*******
 0.24%
*******
*******
*******
*******
Total Assets
*******
 14.32%
*******
*******
*******
*******
Profit or Loss
*******
 -23.85%
*******
*******
*******
*******
Net Worth
*******
 13.71%
*******
*******
*******
*******
EBITDA
*******
 -17.28%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unidrug Innovative Pharma Technologies?

In 2023, Unidrug Innovative Pharma Technologies had a promoter holding of 76.88% and a public holding of 23.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹404,900,000.00

Satisfied Charges

₹168,700,000.00

Charges Breakdown by Lending Institutions
  • Others : 40.49 Cr
Latest Charge Details
Date Lender Amount Status
15 Oct 2024 Others ₹1.50 M Open
29 Jan 2024 Others ₹2.50 M Open
21 Nov 2023 Others ₹1.50 M Open
03 Jul 2020 Others ₹6.70 M Open
28 Apr 2017 Others ₹39.27 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Unidrug Innovative Pharma Technologies?

Unidrug Innovative Pharma Technologies has a workforce of 33 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unidrug Innovative Pharma Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unidrug Innovative Pharma Technologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unidrug Innovative Pharma Technologies
Recent Activity within the Organization
  • Charges

    A charge with Others of Rs. 39.27 Cr registered on 28 Apr 2017 with Charge ID 100097545 was modified on 17 Oct 2025. was recorded as a recent event.

  • Annual General Meeting

    Unidrug Innovative Pharma Technologies Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Unidrug Innovative Pharma Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100999369 was registered on 15 Oct 2024. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100861674 was registered on 29 Jan 2024. was completed.

  • Charges

    A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100829589 was registered on 21 Nov 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unidrug Innovative Pharma Technologies Limited?

The CIN of Unidrug Innovative Pharma Technologies Limited is U85120MP1987PLC003875.

Where is Unidrug Innovative Pharma Technologies Limited headquartered?

Unidrug Innovative Pharma Technologies Limited is headquartered at Plot No. 84 A, Sector - E Sanwer Road, Indore, Madhya Pradesh, 452015.

When was Unidrug Innovative Pharma Technologies Limited incorporated?

Unidrug Innovative Pharma Technologies Limited was incorporated on 13 March 1987.

Who are the current directors of Unidrug Innovative Pharma Technologies Limited?

The current directors of Unidrug Innovative Pharma Technologies Limited are

What is the primary industry of Unidrug Innovative Pharma Technologies Limited?

The primary industry of Unidrug Innovative Pharma Technologies Limited is Manufacturing.

Is Unidrug Innovative Pharma Technologies Limited a listed company?

Unidrug Innovative Pharma Technologies Limited is unlisted.

What is the capital structure of Unidrug Innovative Pharma Technologies Limited?

The authorized capital of Unidrug Innovative Pharma Technologies Limited is ₹20.00 Cr, and the paid-up capital is ₹9.58 Cr.

What is the compliance status of Unidrug Innovative Pharma Technologies Limited?

The compliance status of Unidrug Innovative Pharma Technologies Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available